Purchase Order W81K0224P0043
Award Date
10/1/24
Potential Completion Date
9/30/29
Potential Value
$122K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Inseonmedics Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oro Valley, AZ 85755, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Health Agency to Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, valued at $12,597.00, is for the supply of VENTANA HE600 reagents to support the Brian D. Allgood Army Community Hospital and Biological Defense Automated Analytical Platform in South Korea from October 1, 2023, through September 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDV) with a...
This is a federal contract award from the Defense Health Agency (DHA) to Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, identified as W81K0220D0003|W81K0224F0054, is for the delivery of VENTANA HE600 reagents, which are critical consumables used in immunohistochemistry staining platforms to support military healthcare and biological defense programs at U.S. military medical facilities in South Korea. The contract is a delivery order under an Indefinite...
Inseonmedics Inc. was awarded a $20,305 firm-fixed price delivery order against its single-award indefinite delivery contract with the Defense Health Agency to supply VENTANA HE600 reagents for use at the Brian D. Allgood Army Community Hospital laboratory and Biological Defense Automated Analytical Platform in South Korea. The contract, valued at up to $649,470, provides VENTANA HE600 reagents compatible with immunohistochemistry staining platforms to support medical and biological defense...
The Department of the Army Medical Command awarded a $32,650 firm fixed-price delivery order to Inseonmedics Inc. of South Korea under a blanket purchase agreement for reagents to support the VENTANA HE600 immunohistochemistry staining platform. The reagents will support the U.S. military's laboratory in BDAACH, Korea and must be delivered by September 30, 2020. No set-aside provision was applied to this order to fulfill testing requirements at the Army medical facility in the Republic of...
This delivery order for $45,000 was awarded by the Department of the Army Medical Command to Inseonmedics Inc. for the second delivery of VENTANA HE600 reagents under Option Period I of an indefinite-delivery/indefinite-quantity contract vehicle. The reagents will support the Biological Defense Automated Analytical Platform located in South Korea. Performance will take place in South Korea and be completed by September 30, 2021. No set-aside designation was applied to this award to supply...
The U.S. Defense Health Agency (DHA) awarded a firm fixed price delivery order contract to Synyoung Biomedics, a for-profit company located in South Korea. The contract, valued at $65,507.00, is for the provision of blood gas analyzers and associated reagents to support medical facilities in South Korea that serve U.S. military personnel. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract awarded to Synyoung Biomedics in October 2022, which has a potential value...
This is a firm fixed-price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, a for-profit medical equipment manufacturer and supplier. The $312,341.00 contract is for the provision of reagents, chemistry/immunology equipment, and related services to support the VITROS XT 7600 System and VITROS 500 diagnostic systems at U.S. military medical facilities in South Korea. This order is part of a larger...
This is a firm fixed price delivery order awarded by the Defense Health Agency (DHA) to Chenkwang Science, a for-profit organization based in South Korea. The $22,774.50 contract is for the delivery of Biomerieux reagents to support biological defense analytical capabilities at U.S. military medical treatment facilities in South Korea, such as Brian Allgood Army Community Hospital and the United States Naval Hospital in Okinawa, Japan. The order has an ultimate completion date of September 30,...
This is a firm fixed price delivery order awarded to Chenkwang Science, a for-profit South Korean company, by the Defense Health Agency. The $46,068.75 order is for the delivery of Biomerieux reagents to support clinical diagnostic testing for bacterial pathogens and antimicrobial resistance at U.S. military hospitals in South Korea and Japan. Chenkwang Science is an established federal contractor, holding at least three indefinite delivery contracts with the Department of Defense to provide...
This is a firm fixed price delivery order contract awarded by the U.S. Department of the Army Medical Command (MEDCOM) to Synyoung Biomedics, a South Korean for-profit company. The contract has a ceiling value of $88,417.00 and is for the delivery of reagents for arterial blood gas analyzers to support the Brian D. Allgood Army Community Hospital in South Korea. This delivery order was issued against a larger, single award indefinite delivery contract with a potential value of $421,130.00 that...